Jacobs Solutions (US:J)2025-11-20 15:00Financial Performance - Q4 FY2025 - GAAP gross revenue reached $3.2 billion, a year-over-year increase of 6.6%, while adjusted net revenue was $2.2 billion, up 5.8% year-over-year[10] - Adjusted EBITDA stood at $324 million, reflecting a 12% increase year-over-year, with an adjusted EBITDA margin of 14.4% on adjusted net revenue[10, 14] - Adjusted EPS increased by 27.7% year-over-year to $1.75[10, 14] Financial Performance - FY2025 - GAAP gross revenue was $12.0 billion, up 4.6% year-over-year, and adjusted net revenue was $8.7 billion, up 5.3% year-over-year[10, 17] - Adjusted EBITDA reached $1.2 billion, a 13.9% increase year-over-year, resulting in an adjusted EBITDA margin of 13.9% on adjusted net revenue[10, 17] - Adjusted EPS increased by 15.9% year-over-year to $6.12[10, 17] Backlog and Book-to-Bill Ratio - The company reported a Q4 book-to-bill ratio of 1.1x and a trailing twelve-month (TTM) book-to-bill ratio of 1.1x[10] - Backlog increased from $21.8 billion in 2024 to $23.1 billion in 2025[14, 17] Segment Performance - I&AF End Market (Q4 FY2025) - Critical Infrastructure saw gross revenue of $1.2 billion and adjusted net revenue of $989 million, with year-over-year growth of 5.9% and 9.2% respectively[20] - Water & Environmental had gross revenue of $807 million and adjusted net revenue of $583 million, experiencing a decrease of 4% and 1.1% respectively[20] - Life Sciences & Advanced Manufacturing reported gross revenue of $831 million and adjusted net revenue of $352 million, with year-over-year growth of 19% and 5.3% respectively[20] FY2026 Outlook - The company projects adjusted net revenue growth of 6% to 10% year-over-year[26] - Adjusted EPS is expected to be in the range of $6.90 to $7.30[26] - Free cash flow margin is projected to be between 7% and 8%[26]